Fyous secure £1.4m in investment to transform the lives of diabetics

Founded in 2020, Fyous was originally intended to create bespoke footwear for runners using polymorphic moulding, the company’s proprietary technology. Whilst undertaking market research, Fyous co-founders Joshua Shires and Thomas Bloomfield discovered the challenges around orthotic footwear for diabetics.

More than half of the UK’s diabetics develop neuropathy, a loss of sensation in their feet that can lead to foot damage, ulcers and - in 10,000 cases a year - amputation. Of those amputees, over 70 per cent will die within five years.

Fyous found there was a need for medical footwear that could be manufactured quickly and accurately to provide well-fitting, functional yet stylish footwear that would help with the prevention and management of foot injury and ulceration.

Innovate UK has awarded the company their match-funded award, bringing investment to £1.4m.

In a statement, Bloomfield said: “Creating a shoe that is perfectly moulded to a patient’s feet has historically been elusive, with several alterations required which can take months, with the final shoe not always being the perfect fit.